Target intelligence / Profile preview

Single-stranded DNA and RNA (ssDNA/ssRNA)

Target
ssDNA/ssRNA
Molecular classification
Nucleic acid, Ligand, Genetic material
01

Overview

Single-stranded DNA (ssDNA) and RNA (ssRNA) are fundamental biological polymers that serve as critical intermediates in genetic expression and as potent signaling molecules for the innate immune system. In a physiological context, ssRNA functions primarily as messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA) to facilitate the translation of genetic code into proteins, while ssDNA typically appears during DNA replication and repair processes (Takeda et al., 2005, PMID: 15621742). These molecules are also recognized as pathogen-associated molecular patterns (PAMPs) by endosomal Toll-like receptors, specifically TLR7 and TLR8 for ssRNA and TLR9 for unmethylated CpG motifs in ssDNA, which triggers the production of type I interferons and pro-inflammatory cytokines (Krieg, 2002, PMID: 11994456). In pharmacology, single-stranded nucleic acids are targeted through two main avenues: the administration of synthetic oligonucleotide agonists to stimulate immune responses against viruses and tumors, and the use of antisense oligonucleotides (ASOs) designed to bind complementary ssRNA sequences to treat genetic disorders by altering protein production (Crooke et al., 2018, PMID: 29559000). Dysregulation of these pathways or the presence of autoantibodies against ssDNA is closely linked to the pathogenesis of autoimmune conditions such as systemic lupus erythematosus.

Other names
Single-stranded nucleic acidsssDNAssRNAPolynucleotidesOligonucleotides
02

Mechanism of action

Drugs targeting single-stranded nucleic acids typically act as agonists of pattern recognition receptors (TLR7, TLR8, or TLR9) to induce innate immunity, or utilize antisense technology to hybridize with specific RNA sequences to modulate splicing, induce RNase H-mediated degradation, or block translation.

03

Biological functions

Genetic translationImmune response activationDNA replication intermediateGene expression regulationSignal transduction
04

Disease associations

InfectionCancerAutoimmune diseaseSystemic lupus erythematosusViral pathogenesis
05

Safety considerations

Cytokine release syndromeInduction of autoimmunityOff-target hybridization effectsInjection site reactionsThrombocytopenia
06

Interacting drugs

Imiquimod

8 more in the full profile.

07

Biomarkers

Anti-ssDNA antibodiesType I Interferon (IFN-alpha) levelsViral RNA/DNA loadCirculating tumor DNA (ctDNA)

Beyond the preview

Go deeper on Single-stranded DNA and RNA (ssDNA/ssRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Single-stranded DNA and RNA (ssDNA/ssRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call